Heligenics IDs new interferon beta variants that might help in MS
Heligenics has discovered a number of variations in the interferon beta 1 (IFNB1) gene that may markedly improve the effectiveness of medications containing the interferon beta protein ā a protein widely used in the treatment of multiple sclerosis (MS). The discovery was made using the biotechnology company’s…